FENNEC PHARMACEUTICALS INC.
FENC$315M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaRESEARCH TRIANGLE PARK32 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
10dMarket Overview
Stock performance and key metrics
FENC News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
FENC Earnings Report
Aug 13, 2026Confirmed
EPS Est: $0.01 | FQ end 2026-06
How FENC's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is FENNEC PHARMACEUTICALS INC.'s next FDA catalyst?→
FENNEC PHARMACEUTICALS INC.'s (FENC) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track FENC biotech catalysts?→
Add FENC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow FENNEC PHARMACEUTICALS INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply